| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Enterococcus faecalis (vancomycin-susceptible) |
0.03 |
0.25 |
0.03 － 0.5 |
Telithromycin (HMR 3647, RU-66647, Ketek)  |
496 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.03 |
2 |
0.015 － 2 |
Solithromycin (CEM-101 and OP-1068) |
1130 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.06 |
0.12 |
0.06 － 0.12 |
Dalbavancin |
162 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.06 |
0.12 |
? － ? |
Tigecycline (GAR-936, Tigacyl) |
36 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.06 |
1 |
≤0.01 － 2 |
Teicoplanin (Targocid) |
43 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.06 |
1 |
≤0.01 － 2 |
Teicoplanin (Targocid) |
162 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.06 |
4 |
0.03 － 8 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
1130 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.12 |
0.25 |
≤0.03 － 0.25 |
Teicoplanin (Targocid) |
73 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.12 |
0.25 |
0.06 － 0.25 |
AC98-6446 |
175 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.12 |
0.25 |
≤0.06 － 0.25 |
Tigecycline (GAR-936, Tigacyl) |
462 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.12 |
2 |
0.015 － >16 |
Sitafloxacin |
12 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.12 |
2 |
0.03 － 4 |
Clinafloxacin (PD 127391) |
12 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.25 |
0.25 |
≤0.015 － 0.5 |
Telavancin (TD-6424, Vibativ) |
73 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.25 |
0.25 |
0.06 － 0.25 |
Teicoplanin (Targocid) |
67 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.25 |
0.25 |
0.12 － 0.5 |
Teicoplanin (Targocid) |
175 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.25 |
0.5 |
0.25 － 0.5 |
Tigecycline (GAR-936, Tigacyl) |
175 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.25 |
1 |
0.06 － 2 |
Teicoplanin (Targocid) |
51 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.25 |
4 |
0.015 － 8 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
448 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.25 |
8 |
0.03 － >16 |
Trovafloxacin (Trovan) |
12 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.25 |
8 |
0.06 － >16 |
Moxifloxacin (BAY 12-8039, Avelox) |
12 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.25 |
8 |
0.12 － 8 |
Moxifloxacin (BAY 12-8039, Avelox) |
1060 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.5 |
0.5 |
0.25 － 1 |
Chloroeremomycin (LY264826, A-82846B) |
51 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.5 |
1 |
0.06 － 1 |
Daptomycin + 75 μg/ml Ca++ |
67 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.5 |
1 |
0.06 － 1 |
Oritavancin (LY333328) |
43 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.5 |
1 |
0.06 － 1 |
Oritavancin (LY333328) |
162 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.5 |
1 |
0.5 － 1 |
Amoxicillin-clavulanate |
186 |
| Enterococcus faecalis (vancomycin-susceptible) |
>0.5 |
>2 |
≤0.5 － >2 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
462 |
| Enterococcus faecalis (vancomycin-susceptible) |
0.5 |
8 |
0.007 － 64 |
HMR 3004 (RU 64004) |
448 |